
HSE boss 'shocked' by claims of consultant misuse of waiting list system
The head of the HSE has expressed concern at claims a consultant misused the state's waiting list system, resulting in delayed operations for sick children.
Bernard Gloster was responding to a report in the Sunday Times that a consultant breached HSE guidelines by referring patients he was seeing in his public practice to his weekend private clinics, rather than securing earlier treatment for them by referring them to HSE colleagues.
The newspaper said the consultant was paid thousands of euros through the state's National Treatment Purchase Fund (NTPF), which pays private practices to treat patients on public waiting lists.
According to the report, the details were uncovered by an internal investigation by Children's Health Ireland (CHI).
Mr Gloster said if there was any evidence of misuse of public funds he would refer the matter to the gardai.
The HSE chief executive said he had been unaware of the CHI internal investigation.
"The content of it is absolutely shocking," he told RTE's This Week programme on Sunday.
"Secondly, I'm even more shocked because nobody has told me about it, and in the light of everything we were doing in the last number of months with CHI, I'm just quite shocked.
"And, in fairness to the new CEO (CHI chief executive Lucy Nugent), that's not her fault – I'm not sure how much she has been told. I did speak to her briefly today.
"I believe a number of the issues around culture and other stuff that went on there were addressed, because the report was about more than that.
"But I want to be very clear, I've asked for a copy of the report myself, I have said to the CEO of CHI that I expect her and her board – other than or save for highly personal information – that that report should be published in the public interest.
"And I have made it clear that I reserve my position based on what I see in that report as to whether or not further questions arise and if any question arises, can I assure you, of anything connected with, or near connected with, alleged people ingratiating themselves financially in the public health system, the first step I'll be taking is to refer that matter to the gardai."

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Extra.ie
30 minutes ago
- Extra.ie
‘Serious alarm' over non-medical sales of weight-loss jabs
A warning from the medicines watchdog that weight-loss drugs such as Ozempic are increasingly becoming available through non-medical routes is a cause of 'serious alarm', Independent TD Carol Nolan has said. The Health Products Regulatory Authority (HPRA) issued an 'urgent warning' in recent days about false claims being made online for sales of counterfeit semaglutide, using the HPRA logo. Last December, RTÉ Investigates examined the sale of unapproved US weight-loss medication in Ireland which revealed the extent of the booming black market in the prescription weight-loss drugs. Medical experts were especially worried about serious health risks from the use of weight-loss pens from Turkey, counterfeit semaglutide pens used as an anti-obesity medication, and unlabelled glass vials openly advertised on social media. A warning from the medicines watchdog that weight-loss drugs such as Ozempic are increasingly becoming available through non-medical routes is a cause of 'serious alarm', Independent TD Carol Nolan has said. Pic: Getty Images Ms Nolan said the most alarming feature of the official response was 'increasing concern around off-licence use and access through unofficial sources, which is not supported and poses significant safety risks'. In queries to the HSE, Ms Nolan said: 'I have been contacted by a number of people who have expressed unease regarding the potential adverse health side-effects and long-term harms that may be induced when a person uses Ozempic medication for weight loss.' In a letter to the embattled organisation, Ms Nolan also asked: 'Has the HSE conducted any research on this matter and is the HSE aware of the apparently growing international literature highlighting adverse outcomes for those who use Ozempic?' One source said: 'It is quite common and easily secured. Often it's a mother-daughter bonding before weddings and holidays' Responding, HSE manager Ann Horgan said: 'I have consulted with the National Clinical Programme (NCP) for Obesity on your question and have been informed the NCP is actively monitoring emerging international evidence on the efficacy and safety of GLP-1 receptor agonists, such as semaglutide. 'The HSE was represented at the European Congress of Obesity in Malaga in May 2025, where the use of obesity medications was discussed. When used as licensed and under clinical supervision, the benefits of semaglutide are considered to outweigh the risks for appropriately selected patients.' The HPRA said last week it had seen a 'surge' in misleading website activity in May alone. It said: 'The websites, which are hosted outside of Ireland by the e-commerce platform Shopify, are being directly prompted to consumers via fake Facebook profiles and ads.' Pic: Getty Images Commenting on the concerns, Ms Nolan said: 'I would urge everyone who is considering going down the Ozempic route to limit their engagement to medical professionals prior to embarking on a course of medication. 'I understand there may be a sense of urgency among some people and a sense that they do not have time to wait in terms of accessing a massively over-burdened primary care and hospital service. But the dangers are real and cannot be ignored. 'I would also highlight our need to dramatically ramp up our detection capacity in terms of taking any illegal consignments of Ozempic out of the public space. 'We are all aware of recent media investigations on this issue and still the problem appears to be escalating. 'That is deeply alarming given the potential for such dire health outcomes for people who may be drawn in by ruthless individuals who couldn't give a damn about what impact unregulated medication access causes


Irish Times
2 hours ago
- Irish Times
Revelations show appalling personal behaviour among some CHI medics
With the very future of Children's Health Ireland up for discussion in Government, further revelations about a toxic work culture operating in part of one of its hospitals will bolster the case of those who believe the organisation should simply be subsumed into the Health Service Executive . Even among those who favour its continuation as an independent entity, there are serious doubts as to whether CHI, which is responsible for the governance and operation of the three paediatric hospitals in Dublin – Temple Street , Crumlin and Tallaght – is fit for the job of running the new national children's hospital. Waves of scandal and controversy have overwhelmed the organisation in recent months. A recent report found that most hip surgeries carried out on children were unnecessary . Prior to that, it emerged that devices not cleared for surgical use were inserted into children suffering from scoliosis – the management of which has been another long-running controversy. READ MORE Its chairman and four board members have resigned. The revelations today have been quietly circulating in senior health and political circles in recent days, where they have shocked even the most hardened veterans of scandals in the health services. They paint a picture of an almost unbelievably toxic culture that was operating in a part of one of the CHI hospitals – to the extent that 'numerous participants' who took part in the confidential survey process 'expressed concern for the emotional and physical wellbeing of colleagues working in the service'. [ Report reveals 'toxic culture' among consultants at CHI hospital Opens in new window ] Repeatedly, throughout the report, the conclusions of the observers and the testimony of the employees who participated in its inquiries show that a culture of extreme toxicity characterised the operations of part of the CHI hospital. While one consultant – who is not identified by name in the report – features prominently, there are also complaints about other consultants and a hospital management unable or unwilling to deal with the consequences of the behaviour of some senior medics. Relationships between certain senior clinical figures deteriorated to the extent that one consultant instigated a legal action for defamation against another. 'It is reasonable to assume that such a case can only arise as a result of the fraught relationships within the ... service,' the report notes. 'Fraught relationships' seems to be something of an understatement. The toll on medics who were training under some of the consultants was especially acute. They spoke of 'bullying' and 'harassment', being subjected to 'humiliating and intimidating experiences' and of an 'environment where an individual feels they may be punished or humiliated for speaking up with ideas, questions, concerns or mistakes'. The report also includes details of how the National Treatment Purchase Fund (NTPF) may have been abused by the manipulation of waiting lists. Pointing to a greater number of patients seen in private time slots than at public clinic, it asks: 'Was throughput prioritised over patient care in NTPF clinics, noting there is a €200 fee per patient, or are the public outpatient clinics failing to operate at full capacity?' Yesterday, the Sunday Times reported that Minister for Health Jennifer Carroll MacNeill had ordered a full audit of governance and practices at CHI. There are very clearly significant systemic failings in parts of the organisation and in the hospitals for which it is responsible. But the revelations today show something else too: appalling personal behaviour by some senior medics which damaged the care that patients in the hospitals received. Some trainees felt punished and excluded, belittled and victimised, to the extent that some felt that the experience – 'working in a hostile environment', as one said – had a detrimental effect on their lives. Aside from the personal consequences for people subjected to the behaviour of some senior colleagues, the report points out repeatedly that it creates an atmosphere that damages the care of patients. Aside from individual instances detailed in the report, the toxic relationships also poison the atmosphere where people are supposed to be working together for the benefit of the patients. 'The communication style, accusatory language and indeed unprofessional antics that continued over this period add to further compromise interpersonal relations, heighten levels of mistrust among colleagues and ultimately are a distraction from patient-centric care,' it found. 'Consistently throughout this examination, it was found that participant experiences reflected a culture in which challenging behaviour appears to be the norm,' the report found. 'It is critical that an organisation takes time to reflect on and own the culture that exists and then seeks to address the issues and bring about the required change.'


Irish Times
3 hours ago
- Irish Times
Fund set up by Micheál Martin 20 years ago to cut hospital waiting lists under fresh scrutiny
In February, Jennifer Carroll MacNeill became the latest Minister for Health to announce a new initiative to reduce the amount of time patients have to wait for treatment in public hospitals . The Irish health system has been struggling for years to deal with growing waiting lists with bed and staffing capacity lagging behind demand. The answer for successive governments has been to either use the private sector or to get existing personnel to do more in their own time, while the Health Service Executive moved to increase its own resources. The amount of money allocated to these initiatives has been staggering. The Minister's plan in February involved a €420 million investment, including €190 million for the HSE and €230 million for the National Treatment Purchase Fund (NTPF) – the organisation established by Micheál Martin 20 years ago to buy treatment for public patients. READ MORE Between 2022 and 2024 under Stephen Donnelly , about €1.23 billion was allocated to the HSE and the NTPF. Government funding was essentially spent in three ways. First, it allowed the HSE to appoint more staff to increase its own capacity. Second, it allowed the NTPF to buy care in private facilities. Third, it allowed for what is known as 'insourcing', where health service personnel are paid by the NTPF or other entities to provide treatment outside normal hours in public hospitals for those on waiting lists. A recent internal report carried out by children's healthcare group CHI , has led to more intense scrutiny of the various waiting list initiatives. The report alleged that a doctor had delayed operations on children before eventually they were treated at weekend clinics that he was operating separately. In the Dáil, the Taoiseach said the CHI report 'makes for shocking reading of the most profound kind, which not just goes to the heart of the misuse of NTPF funding but more seriously raises fundamental concerns at that time about safety for children receiving surgery'. Cian O'Callaghan of the Social Democrats told the Dáil that the report found the consultant earned more than €35,000 by keeping very young children on a waiting list for years. 'They were eventually treated using the NTPF when they were transferred to the consultant's weekend clinic, but they could have been treated by other doctors years earlier. When all of this was discovered, it was kept a secret and the consultant was allowed to retire and sail into the sunset.' The Minister and HSE chief Bernard Gloster had been kept in the dark about the report but were given copies last week. There have been other controversies surrounding waiting list funding. On April 18th, Mr Gloster directed his senior leadership team to halt, for the present at least, aspects of the 'insourcing' arrangements. He commissioned a survey to establish the dependency of the health system on such practices and to ensure 'there were no unintended consequences'. Mr Gloster suspended insourcing where staff were 'engaged, hired or paid' by separate entities on initiatives in their area of work. Insourcing was only permitted in cases where the HSE directly engaged its own staff through payroll. His instructions followed discussions with Ms Carroll MacNeill and followed an internal audit report, details of which were revealed in The Irish Times last September. The HSE internal audit found two companies which received more than €1.5 million between them in contracts awarded by University Hospital Limerick without a competitive procurement process were owned or part-owned by employees at the facility. A third company, which received a contract of nearly €400,000, had a HSE employee at a different hospital as a director. Auditors stated €14.2 million was paid out to third-party providers by University Hospital Limerick in 2023 under the Government waiting list initiative without an open procurement process. Auditors said there was no evidence of the HSE employees being involved in the awarding of the contracts. In May, Aontú leader Peadar Tóibín told the Dáil in one case a consultant created a firm to read scans and 'used the hospital public waiting lists to then funnel work through rostering into his own private company'. The NTPF said it was deeply concerned at the CHI internal report. It said it had never received any complaints about hospitals or doctors. Last year, the fund paid €155 million to private hospitals and about €80 million to public facilities. It seeks private hospitals to tender for packages of care and it then attempts to match this capacity with those waiting longest in public facilities. Sara Burke, associate professor of health policy at Trinity College, said the NTPF and the various waiting list initiatives were initially established more than 20 years ago as temporary measures while the State built up its own public capacity. They had, however, become permanent, integral parts of the system, she said. 'Given the amounts of money now being allocated, there is a need to look at how transparent the arrangements are and the governance of these schemes,' she said. The Opposition is now calling for reforms. David Cullinane of Sinn Féin said there were concerns about potential conflicts of interest and called for a centralised system which would see patients referred to a hospital rather than an individual consultant. 'We have to ask genuine questions about what work some consultants are doing from Monday to Friday to carry out public procedures. We need to contrast that with the so-called blitzes and private clinics they are organising and running, while charging €200 for each client they see and making very handsome amounts of money.' Marie Sherlock of the Labour Party said she was uncomfortable about how the current arrangements had grown, the dependency on it that had developed and 'the ability of the public system to wean itself off it'. Mr Tóibín questioned the safeguards in place against conflicts of interest. 'Last year 80,000 public patients were treated in private hospitals at a cost of €100 million. The majority of these treatments should have been done in the public system.' Ms Carroll MacNeill told the Dáil she would be taking further steps to remove the anomalies, which she said existed 'because of the overhanging mix of public and private activity'.